Movement Control Exercises and Fascial Manipulation in Chronic Low Back Pain
NCT ID: NCT03270631
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
250 participants
INTERVENTIONAL
2017-08-28
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Fascial Manipulation for Chronic Low Back Pain
NCT01269983
Changing Trunk Muscle Activation in Patients With Recurrent Low Back Pain in Remission
NCT06452030
Efficacy of Passive Joint Mobilization vs Mobilization With Movement on Pain Processing in Patients With Chronic Low Back Pain
NCT04940715
Relationship Between Clinical Tests and Clinical Outcomes After Motor Control Exercises Intervention
NCT02398760
The Quality of Physiotherapy in Low Back Pain Patients in Central Finland
NCT04034186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Multidisciplinary rehabilitation, no interventions
No interventions assigned to this group
FM and MCE
Subjects will have 4-5 times of fascial manipulation (FM) treatment and 4-6 times movement control exercises (MCE) at home to be done based on movement control testing (MCT). Both are given in 3 month period.
FM and MCE
Treatments (FM and MCE) are given individually and as in a normal clinical physical therapy setting.
FM and sham-MCE
FM 4-5 times in 3 months and 4 general exercise prescription.
FM and sham-MCE
Treatments (FM) are given individually and as in a normal clinical physical therapy setting. Sham-MCE is general exercises.
MCE and sham-FM
Sham-FM 4 times in 3 months including trigger point treatment in before decided points and 4-6 times MCE prescription and home exercises.
MCE and sham-FM
Treatments (FM and MCE) are given individually and as in a normal clinical physical therapy setting. Sham-FM is similar to trigger point treatment with treated points randomized.
Sham-MCE and sham-FM
4 general practice guiding and Sham-FM 4 times in 3 months including trigger point treatment in before decided points.
Sham-MCE and sham-FM
Sham-FM is similar to trigger point treatment with treated points randomized. Sham-MCE is general exercises.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FM and MCE
Treatments (FM and MCE) are given individually and as in a normal clinical physical therapy setting.
FM and sham-MCE
Treatments (FM) are given individually and as in a normal clinical physical therapy setting. Sham-MCE is general exercises.
MCE and sham-FM
Treatments (FM and MCE) are given individually and as in a normal clinical physical therapy setting. Sham-FM is similar to trigger point treatment with treated points randomized.
Sham-MCE and sham-FM
Sham-FM is similar to trigger point treatment with treated points randomized. Sham-MCE is general exercises.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Loisto Terveys, Oulu
UNKNOWN
Fysios Kastelli, Oulu
UNKNOWN
Faskia-Markus, Oulu
UNKNOWN
Oulu University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jani Takatalo
Resident of PRM, PhD, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jani Takatalo, PhD
Role: PRINCIPAL_INVESTIGATOR
Oulu University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Oulu
Oulu, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FM&KCStudy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.